Citrate level in osteoporotic women treated with estrogen and alendronate

被引：0
|
作者：
D'Amelio, P
Beccattini, W
Pescarmona, GP
Isaia, GC
机构：
[1] Univ Turin, Dept Gen Biol & Biochem, I-10124 Turin, Italy
[2] Univ Turin, Dept Internal Med, I-10124 Turin, Italy
来源：
OSTEOPOROSIS INTERNATIONAL | 2000年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
374
引用
收藏
页码：S156 / S156
页数：1
相关论文
共 50 条
  • [41] Can alendronate be taken before lunch or dinner? A randomized trial in osteoporotic women
    Delmas, PP
    Confavreux, E
    Genolet, G
    Gamero, P
    Gibelin, B
    Folens, C
    Yates, J
    OSTEOPOROSIS INTERNATIONAL, 2000, 11 : S208 - S208
  • [42] Placebo-controlled multicenter study of oral alendronate in postmenopausal osteoporotic women
    Felsenberg, D
    Alenfeld, F
    Beck, O
    Hammermeister, C
    Gowan, W
    MATURITAS, 1998, 31 (01) : 35 - 44
  • [43] BMD response to alendronate in osteoporotic women with secondary hyperparathyroidism is related to Pth changes
    Giusti, A.
    Barone, A.
    Pioli, G.
    Girasole, G.
    Razzano, M.
    Pizzonia, M.
    Palummeri, E.
    Bianchi, G.
    BONE, 2007, 40 (06) : S207 - S207
  • [44] Use and side effect profile of alendronate in osteoporotic women in Turkey:: Preliminary results
    Eskiyurt, N
    Arasil, T
    Öncel, S
    Aki, S
    Bütün, B
    Çetin, A
    Çogalgil, S
    Gür, A
    Gürsoy, S
    Kirazli, Y
    Öncel, A
    Özbek, L
    Sepici, V
    Tosun, M
    Uguriu, H
    Uysal, F
    Eryavuz, M
    OSTEOPOROSIS INTERNATIONAL, 2000, 11 : S16 - S16
  • [45] Effects of alendronate combined with hormone replacement therapy on osteoporotic postmenopausal Chinese women
    Tseng, Li-Nien
    Sheu, Wayne Huey-Herng
    Ho, Esther Shih-Chu
    Lan, Howard Haw-Chang
    hu, Cng-Chieh Hu
    Kao, Chia-Hung
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2006, 55 (06): : 741 - 747
  • [46] Influence of alendronate on periosteal and endocortical bone formation in the ilium of osteoporotic women.
    Bare, S
    Recker, S
    Recker, R
    Kimmel, D
    JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (09) : S96 - S96
  • [47] Effect of alendronate and combined hormone replacement therapy in Taiwanese postmenopausal osteoporotic women
    Chen, JF
    Huang, JS
    Lin, JD
    OSTEOPOROSIS INTERNATIONAL, 2000, 11 : S184 - S185
  • [48] Can alendronate be taken before lunch or dinner? A randomized trial in osteoporotic women
    Delmas, PD
    Confavreux, E
    Garnero, P
    BONE, 2002, 30 (03) : 56S - 56S
  • [49] Impact of noncompliance with alendronate and risedronate on the incidence of nonvertebral osteoporotic fractures in elderly women
    Blouin, Julie
    Dragomir, Alice
    Moride, Yola
    Ste-Marie, Louis-Georges
    Fernandes, Julio Cesar
    Perreault, Sylvie
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 66 (01) : 117 - 127
  • [50] PPARG PROMOTER POLYMORPHISM IS ASSOCIATED WITH RESPONSIVENESS TO ALENDRONATE TREATMENT IN POSTMENOPAUSAL OSTEOPOROTIC WOMEN
    Dragojevic, J.
    Ostanek, B.
    Bedrac, S. Mencej
    Prezelj, J.
    Marc, J.
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2011, 44 : 53 - 54
12345